NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

I have to wonder the expanded benefit of DCVax-L with the clinical constraints not there, when being used in a normal cancer therapy environment. The volumes of patients who could saved from an early death sentence with SOC now in place. To have that option and the mental readjustment helping, in contrast to the lack of hope given by current SOC.

DCVax-direct may be given a huge boost in clinical due to DCVax-L successes.